一种基于酸伊米达酸框架的抗微生物递送系统,具有增强的抗癌活性和低系统毒性
Jingwen Jiang1, Kaderya Kaysar1, Yanzhu Pan1
1Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830046, China.
Pharmaceutics
|January 8, 2025
概括
这项研究开发了CEC@ZIF-8纳米粒子,用于向治疗宫癌. 这种新型纳米药物输送系统在临床前模型中证明了提高疗效和降低毒性,提供了一个有前途的治疗策略.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 抗癌药物的疗效受到非选择性毒性和瘤生物可用性差的限制.
- 针对性的药物输送系统对于改善癌症治疗中的患者存活率至关重要.
研究的目的:
- 开发和评估一种新的纳米药物输送系统,CEC@ZIF-8,用于增强宫癌治疗.
- 评估CEC@ZIF-8在向药物输送和瘤破坏方面的体外和体内性能.
主要方法:
- 制造和表征CEC@ZIF-8纳米颗粒使用酸伊米达框架-8 (ZIF-8)作为载体.
- 在宫癌细胞中细胞毒性,细胞吸收和药物释放的体外评估.
- 在TC-1瘤携带小鼠模型中对抗宫癌活性的体内评估.
主要成果:
- CEC@ZIF-8表现出良好的生物相容性,对pH响应的药物释放,以及在癌细胞中增强的细胞内积累.
- 转录组分析揭示了细胞周期和细胞亡相关的途径,这些途径是CEC@ZIF-8.
- 在体内研究表明,与传统治疗相比,显著抑制瘤生长,降低了全身毒性.
结论:
- CEC@ZIF-8纳米药物输送系统显著增强了CEC的抗宫癌效果.
- 该系统显示了在向瘤管理和选择性破坏癌症组织方面的临床应用潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


